Grufity logo
Grufity logo
XXII

XXII - 22nd Century Group Inc Stock Price, Fair Value and News

$1.82-0.17 (-8.54%)
Market Closed as of 14 Sep 2026, 04:00 pm ET

XXII Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

XXII Price Action

Last 7 days

-25.7%

Last 30 days

-57.9%

Last 90 days

-68.3%

Trailing 12 Months

-99.7%

XXII RSI Chart

XXII Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

XXII Valuation

Market Cap

1.3M

Price/Earnings (Trailing)

-0.33

Price/Sales (Trailing)

0.09

EV/EBITDA

0.21

Price/Free Cashflow

-0.15

XXII Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

XXII Fundamentals

XXII Revenue

Revenue (TTM)

14.5M

Rev. Growth (Yr)

-29.86%

Rev. Growth (Qtr)

-30.23%

XXII Earnings

Earnings (TTM)

-3.9M

Earnings Growth (Yr)

1.79%

Earnings Growth (Qtr)

-2.61%

XXII Profitability

Operating Margin

45.00%

EBT Margin

-88.34%

Return on Equity

-21.06%

Return on Assets

-15%

Free Cashflow Yield

-673.66%

XXII Investor Care

Shares Dilution (1Y)

70944.18%

Diluted EPS (TTM)

9.8K

Revenue & Growth

How 22nd Century Group Inc generates revenue and covers its expenses, based on the latest reported earnings.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
202615.7M14.5M--
202523.9M20.0M18.1M17.6M
202429.7M29.6M27.7M24.4M
202340.4M38.5M34.8M32.2M
202232.0M34.2M37.4M40.5M
202129.0M30.4M31.4M30.9M
202026.6M27.2M28.1M28.1M
201926.6M25.5M25.7M25.8M
201820.5M23.5M25.2M26.4M
201711.5M12.6M14.0M16.6M
20169.3M10.8M11.5M12.3M
2015697.6K3.0M5.6M8.5M
2014510.2K742.0K754.0K529.0K
2013--148.6K278.4K
2012--515.5K18.8K
2011290.4K531.0K771.6K1.0M
2010---49.8K
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About 22nd Century Group Inc

XXII
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
 CEO
 WEBSITExxiicentury.com
 SECTORConsumer Defensive
 INDUSTRYTobacco
 EMPLOYEES198

22nd Century Group Inc Frequently Asked Questions

XXII is the stock ticker symbol of 22nd Century Group Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Mon Sep 14 2026, market cap of 22nd Century Group Inc is 1.3 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Mon Sep 14 2026, XXII's PE ratio (Price to Earnings) is -0.33 and Price to Sales (PS) ratio is 0.09. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. XXII PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, 22nd Century Group Inc has provided -0.832 (multiply by 100 for percentage) rate of return.